This page is part of the FHIR Specification (v5.0.0: R5 - STU). This is the current published version in it's permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3
Pharmacy Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Encounter, Patient, Practitioner |
Raw XML (canonical form + also see XML Format Specification)
Request for Intravenous Chemotherapy (inpatient order) - Alemtuzumab - completed with multiple dosageInstruction lines (id = "medrx0317")
<?xml version="1.0" encoding="UTF-8"?> <MedicationRequest xmlns="http://hl7.org/fhir"> <id value="medrx0317"/> <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"><p> <b> Generated Narrative: MedicationRequest</b> <a name="medrx0317"> </a> </p> <div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource MedicationRequest "medrx0317" </p> </div> <p> <b> identifier</b> : id: 12345689 (use: OFFICIAL)</p> <p> <b> status</b> : completed</p> <p> <b> intent</b> : order</p> <h3> Medications</h3> <table class="grid"><tr> <td> -</td> <td> <b> Reference</b> </td> </tr> <tr> <td> *</td> <td> <a name="med0303"> </a> <blockquote> <p/> <p> <a name="med0303"> </a> </p> <p> <b> code</b> : Alemtuzumab 10mg/ml (Lemtrada) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.1.0/CodeSystem-v3-rxNorm.html">RxNorm</a> #1594660)</span> </p> </blockquote> </td> </tr> </table> <p> <b> subject</b> : <a href="patient-example-a.html">Patient/pat1: Donald Duck</a> "Donald DUCK"</p> <p> <b> authoredOn</b> : 2015-01-15</p> <p> <b> requester</b> : <a href="practitioner-example-f007-sh.html">Practitioner/f007: Patrick Pump</a> "Simone HEPS"</p> <h3> Reasons</h3> <table class="grid"><tr> <td> -</td> <td> <b> Concept</b> </td> </tr> <tr> <td> *</td> <td> Chronic Lymphoid Leukemia (disorder) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a> #92814006)</span> </td> </tr> </table> <blockquote> <p> <b> dosageInstruction</b> </p> <p> <b> sequence</b> : 1</p> <p> <b> text</b> : Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk</p> <p> <b> additionalInstruction</b> : Rapidly increase dose until tolerated <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> ()</span> , Administer on alternate days <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> ()</span> </p> <p> <b> timing</b> : Duration 12weeks, 3 per 1 weeks</p> <p> <b> route</b> : Intravenous route (qualifier value) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a> #47625008)</span> </p> <p> <b> method</b> : Inject - dosing instruction imperative (qualifier value) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a> #422145002)</span> </p> <blockquote> <p> <b> doseAndRate</b> </p> </blockquote> </blockquote> <blockquote> <p> <b> dosageInstruction</b> </p> <p> <b> sequence</b> : 2</p> <p> <b> text</b> : Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk</p> <p> <b> additionalInstruction</b> : Rapidly increase dose until tolerated <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> ()</span> , Administer on alternate days <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> ()</span> </p> <p> <b> timing</b> : Duration 12weeks, 3 per 1 weeks</p> <p> <b> route</b> : Intravenous route (qualifier value) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a> #47625008)</span> </p> <p> <b> method</b> : Inject - dosing instruction imperative (qualifier value) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a> #422145002)</span> </p> <blockquote> <p> <b> doseAndRate</b> </p> </blockquote> </blockquote> <blockquote> <p> <b> dosageInstruction</b> </p> <p> <b> sequence</b> : 3</p> <p> <b> text</b> : Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk</p> <p> <b> additionalInstruction</b> : Rapidly increase dose until tolerated <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> ()</span> , Administer on alternate days <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> ()</span> </p> <p> <b> timing</b> : Duration 12weeks, 3 per 1 weeks</p> <p> <b> route</b> : Intravenous route (qualifier value) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a> #47625008)</span> </p> <p> <b> method</b> : Inject - dosing instruction imperative (qualifier value) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a> #422145002)</span> </p> <blockquote> <p> <b> doseAndRate</b> </p> </blockquote> </blockquote> </div> </text> <contained> <Medication> <id value="med0303"/> <code> <coding> <system value="http://www.nlm.nih.gov/research/umls/rxnorm"/> <code value="1594660"/> <display value="Alemtuzumab 10mg/ml (Lemtrada)"/> </coding> </code> </Medication> </contained> <identifier> <use value="official"/> <system value="http://www.bmc.nl/portal/prescriptions"/> <value value="12345689"/> </identifier> <status value="completed"/> <intent value="order"/> <medication> <reference> <reference value="#med0303"/> </reference> </medication> <subject> <!-- Linked to the resource patient who needs the medication --> <reference value="Patient/pat1"/> <display value="Donald Duck"/> </subject> <authoredOn value="2015-01-15"/> <requester> <reference value="Practitioner/f007"/> <display value="Patrick Pump"/> </requester> <reason> <concept> <coding> <system value="http://snomed.info/sct"/> <code value="92814006"/> <display value="Chronic Lymphoid Leukemia (disorder)"/> </coding> </concept> </reason> <dosageInstruction> <sequence value="1"/> <text value="Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk"/> <additionalInstruction> <text value="Rapidly increase dose until tolerated"/> </additionalInstruction> <additionalInstruction> <text value="Administer on alternate days"/> </additionalInstruction> <timing> <repeat> <duration value="12"/> <durationUnit value="wk"/> <frequency value="3"/> <period value="1"/> <periodUnit value="wk"/> </repeat> </timing> <route> <coding> <system value="http://snomed.info/sct"/> <code value="47625008"/> <display value="Intravenous route (qualifier value)"/> </coding> </route> <method> <coding> <system value="http://snomed.info/sct"/> <code value="422145002"/> <display value="Inject - dosing instruction imperative (qualifier value)"/> </coding> </method> <doseAndRate> <type> <coding> <system value="http://terminology.hl7.org/CodeSystem/dose-rate-type"/> <code value="ordered"/> <display value="Ordered"/> </coding> </type> <doseQuantity> <value value="3"/> <unit value="mg"/> <system value="http://unitsofmeasure.org"/> <code value="mg"/> </doseQuantity> </doseAndRate> </dosageInstruction> <dosageInstruction> <sequence value="2"/> <text value="Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk"/> <additionalInstruction> <text value="Rapidly increase dose until tolerated"/> </additionalInstruction> <additionalInstruction> <text value="Administer on alternate days"/> </additionalInstruction> <timing> <repeat> <duration value="12"/> <durationUnit value="wk"/> <frequency value="3"/> <period value="1"/> <periodUnit value="wk"/> </repeat> </timing> <route> <coding> <system value="http://snomed.info/sct"/> <code value="47625008"/> <display value="Intravenous route (qualifier value)"/> </coding> </route> <method> <coding> <system value="http://snomed.info/sct"/> <code value="422145002"/> <display value="Inject - dosing instruction imperative (qualifier value)"/> </coding> </method> <doseAndRate> <type> <coding> <system value="http://terminology.hl7.org/CodeSystem/dose-rate-type"/> <code value="ordered"/> <display value="Ordered"/> </coding> </type> <doseQuantity> <value value="10"/> <unit value="mg"/> <system value="http://unitsofmeasure.org"/> <code value="mg"/> </doseQuantity> </doseAndRate> </dosageInstruction> <dosageInstruction> <sequence value="3"/> <text value="Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk"/> <additionalInstruction> <text value="Rapidly increase dose until tolerated"/> </additionalInstruction> <additionalInstruction> <text value="Administer on alternate days"/> </additionalInstruction> <timing> <repeat> <duration value="12"/> <durationUnit value="wk"/> <frequency value="3"/> <period value="1"/> <periodUnit value="wk"/> </repeat> </timing> <route> <coding> <system value="http://snomed.info/sct"/> <code value="47625008"/> <display value="Intravenous route (qualifier value)"/> </coding> </route> <method> <coding> <system value="http://snomed.info/sct"/> <code value="422145002"/> <display value="Inject - dosing instruction imperative (qualifier value)"/> </coding> </method> <doseAndRate> <type> <coding> <system value="http://terminology.hl7.org/CodeSystem/dose-rate-type"/> <code value="ordered"/> <display value="Ordered"/> </coding> </type> <doseQuantity> <value value="30"/> <unit value="mg"/> <system value="http://unitsofmeasure.org"/> <code value="mg"/> </doseQuantity> </doseAndRate> </dosageInstruction> </MedicationRequest>
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.
FHIR ®© HL7.org 2011+. FHIR R5 hl7.fhir.core#5.0.0 generated on Sun, Mar 26, 2023 15:25+1100.
Links: Search |
Version History |
Contents |
Glossary |
QA |
Compare to R4 |
Compare to R4B |
|
Propose a change